C-2 Arylated benzo[b]thiophene Derivatives as staphylococcus aureus norA eflux pump inhibitors - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue ChemMedChem Année : 2016

C-2 Arylated benzo[b]thiophene Derivatives as staphylococcus aureus norA eflux pump inhibitors

Résumé

An innovative and straightforward synthesis of second-generation 2-arylbenzo[b]thiophenes as structural analogues of INF55 and the first generation of our laboratory-made molecules was developed. The synthesis of C2-arylated benzo[b]thiophene derivatives was achieved through a method involving direct arylation, followed by simple structural modifications. Among the 34 compounds tested, two of them were potent NorA pump inhibitors, which led to a 16-fold decrease in the ciprofloxacin minimum inhibitory concentration (MIC) against the SA-1199B strain at concentrations of 0.25 and 0.5 μg mL(-1) (1 and 1.5 μm, respectively). This is a promising result relative to that obtained for reserpine (MIC=20 μg mL(-1)), a reference compound amongst NorA pump inhibitors. These molecules thus represent promising candidates to be used in combination with ciprofloxacin against fluoroquinolone-resistant strains.

Dates et versions

hal-01477632 , version 1 (27-02-2017)

Identifiants

Citer

F. Ligier, P. Bouhours, C. Ganem-Elbaz, C. Jolivalt, S Pellet-Rostaing, et al.. C-2 Arylated benzo[b]thiophene Derivatives as staphylococcus aureus norA eflux pump inhibitors. ChemMedChem, 2016, 11 (3), pp.320-330. ⟨10.1002/cmdc.201500463⟩. ⟨hal-01477632⟩
123 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More